Real-world outcomes of 600 drug-coated balloon angioplasties.

Introduction: The principal challenge in maintaining functional vascular access for hemodialysis is managing outflow stenoses, which are primarily caused by intimal hyperplasia. These stenoses are the leading cause of access dysfunction, leading to inadequate dialysis, increased morbidity, and frequent reinterventions. While drug-coated balloons (DCBs) have emerged as a promising solution by delivering antiproliferative agents to reduce restenosis rates, further clinical insights are needed to establish their role in vascular access management.

Preservation of vascular access in aneurysmal native fistulas: Ten years of stapled aneurysmoplasty.

Introduction: Aneurysmal degeneration of autogenous arteriovenous fistulas represents an increasingly prevalent complication in long-term dialysis patients, often leading to access failure and significant morbidity. Despite the clinical relevance, consensus on optimal surgical management remains limited.

Methods: We present a 10-year single-center experience with a modified stapling technique for AVF aneurysmoplasty, aimed at preserving native access while enabling immediate post-operative cannulation.

Sizing matters not: Technical standardization of small anastomoses in AVF surgery for complex patients.

Introduction: Arteriovenous fistulas (AVFs) remain the preferred vascular access for hemodialysis, though failure to mature, juxta-anastomotic stenosis, and distal hypoperfusion ischemic syndrome (DHIS) continue to limit their effectiveness. We evaluated a standardized approach combining small-size anastomoses (SSA) and the piggyback Straight-Line Onlay Technique (pSLOT) to improve outcomes in complex AVF creation.

Materials And Methods: This single-center prospective study included all consecutive patients referred for AVF creation from January 2022 to December 2023.

Optimizing the life of vascular access during follow-up.

Optimizing the longevity of vascular access in hemodialysis patients remains a critical aspect of patient care, given the significant role of arteriovenous fistulas (AVFs) and arteriovenous grafts (AVGs) in enabling effective dialysis. Vascular access complications, such as stenosis, thrombosis, and cannulation-related damage, continue to challenge both the functionality and the sustainability of these access points. Recent advancements underscore the importance of a robust follow-up strategy, integrating clinical evaluations with diagnostic tools like color Doppler ultrasound (CDU) and emerging interventional approaches such as drug-coated balloon (DCB) angioplasty.

Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm.

Objectives: Thoracic/abdominal aortic aneurysms and aortic stenosis may be concomitant diseases requiring both transcatheter aortic valve implantation (TAVI) and endovascular aneurysm repair (T/EVAR) in high-risk patients for surgical approaches, but temporal management is not clearly defined yet. The aim of the study was to analyse outcomes of simultaneous versus staged TAVI and T/EVAR.

Methods: Retrospective observational multicentre study was performed on patients requiring TAVI and T/EVAR from 2016 to 2022.

Predicting early mortality following single-stage coronary artery or valve surgery and carotid endarterectomy.

Background: Surgical management of coexisting cardiac disease and extra-cranial carotid artery disease is a controversial area of debate. Thus, in this challenging scenario, risk stratification may play a key role in surgical decision making.

Aim: To report the results of single-stage coronary/valve surgery (CVS) and carotid endarterectomy (CEA), and to identify predictive factors associated with 30-day mortality.

Systemic inflammation index as useful tool to predict arteriovenous graft stenosis: Our experience and literature review.

Objective: Many studies show that settings of severe inflammatory stress might be responsible for changes in circulating blood cells count. Effective inflammation indices are created calculating the quantitative relationship between these cells. No previous studies have been proposed on hemodialysis patients exploring the association between arteriovenous graft (AVG) stenosis and systemic inflammation markers, such as Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and systemic-immune-inflammation index (SII).

Endovascular Reconstruction for Total Aorto-Iliac Occlusion.

Objectives: To analyze outcomes following endovascular treatment of total occlusion of the infrarenal aorta and aorto-iliac bifurcation in a multicenter Italian registry.

Methods: It is a multicenter, retrospective, observational cohort study. From January 2015 to December 2018, 1306 endovascular interventions for aorto-iliac occlusive disease were recorded in the vascular registry.

Outcomes of stent-graft repair for anastomotic femoral pseudoaneurysm. A case series.

Objective: This study aims to report a case series of anastomotic femoral pseudoaneurysms (PSA) treated with stent-grafting (SG) in patients at high-risk for the open surgical approach.

Methods: It is a retrospective, observational cohort study. Between 1 January 2002 and 1 April 2020, post-hoc analysis of the database including patients who received repair for femoral PSA identified those treated with SG.

Outcomes Analysis of Surgical Conversion for Kissing-Stent Occlusion.

Background: We aimed to describe the operative outcomes following open aortoiliac/femoral graft reconstruction for bilateral kissing-stent (KS) occlusion.

Methods: This is a bicentric, retrospective, observational cohort study. Between September 2007 and December 2019, 205 patients were treated with KS for aortoiliac reconstruction.

Hybrid arteriovenous graft for hemodialysis vascular access in a multicenter registry.

Objective: The aim of our study was to identify patients' characteristics that predicted a higher chance of arteriovenous graft patency in patients undergoing Gore Hybrid Vascular Graft (GHVG; W. L. Gore & Associates, Flagstaff, Ariz) implantation for hemodialysis access.